Condition: Non-Muscle Invasive Bladder Neoplasms · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to assess how well TAR-200 works in real-word by measuring the time taken from the first TAR-200 insertion to worsening of cancer or until the signs and symptoms of cancer occur again (disease-free survival) in participants with non-muscle invasive bladder cancer (NMIBC; an early-stage bladder cancer that is limited to the inner lining of bladder).
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Eliza M. Raymundo, MD, DMCC, FPUA, FPCS · 1-669-800-7705
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Arkansas Urology | Little Rock, Arkansas, United States | Recruiting |
| USC Norris Comprehensive Cancer Center | Los Angeles, California, United States | Recruiting |
| Cedars Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| Colorado Clinical Research | Lakewood, Colorado, United States | Recruiting |
| Florida Urology Partners | Wimauma, Florida, United States | Recruiting |
| Indiana University Melvin and Bren Simon Cancer Center | Indianapolis, Indiana, United States | Recruiting |
| Specialty Clinical Research of St Louis | St Louis, Missouri, United States | Recruiting |
| SUNY Upstate Med Univ | Syracuse, New York, United States | Recruiting |
| Urology Specialists of the Carolinas PLLC Charlotte | Charlotte, North Carolina, United States | Recruiting |
| Urology Specialists of South Dakota | Sioux Falls, South Dakota, United States | Recruiting |
| UPNT Research Institute | Arlington, Texas, United States | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07309445